Showing results (51-60 of 195) with videos related to
Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|February 1, 1993
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donorsJ M Romeo, P P Ulrich, M P Busch, et al.Transfusion|May 22, 2003
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donationsB R Jackson, M P Busch, S L Stramer, et al.Transfusion|October 6, 1997
Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screeningL H Tobler, E Kaufman, N Gefter, et al.Transfusion Medicine (Oxford, England)|November 4, 1998
A prospective study of the risk of transfusion-acquired viral infectionsE L Murphy, M P Busch, M Tong, et al.Emerging Infectious Diseases|August 4, 2001
Emerging infectious disease issues in blood safetyM E Chamberland, H J Alter, M P Busch, et al.Transfusion|May 11, 2001
Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibilityT H Lee, W Reed, L Mangawang-Montalvo, et al.Blood|April 27, 1999
Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patientsT H Lee, T Paglieroni, H Ohto, et al.Blood|November 15, 1990
Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplificationB D Rawal, R Schwadron, M P Busch, et al.Transfusion|April 25, 2000
Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test resultsM P Busch, W M Switzer, E L Murphy, et al.AIDS (London, England)|March 15, 1997
Divergence of HIV-1 quasispecies in an epidemiologic clusterR S Diaz, L Zhang, M P Busch, et al.Pageof 20